Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in Melanoma.
Adv Ther (Weinh)
; 3(8)2020 Aug.
Article
in En
| MEDLINE
| ID: mdl-35754977
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Adv Ther (Weinh)
Year:
2020
Document type:
Article
Affiliation country:
Israel